IBERE PHARMACEUTICALS's ticker is IBERU and the CUSIP is G46843127. A total of 35 filers reported holding IBERE PHARMACEUTICALS in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $572,996 | -16.4% | 57,472 | -16.9% | 0.00% | – |
| Q3 2022 | $685,000 | +22.3% | 69,179 | +21.1% | 0.00% | – |
| Q2 2022 | $560,000 | +1.1% | 57,139 | +1.1% | 0.00% | – |
| Q1 2022 | $554,000 | -2.3% | 56,545 | 0.0% | 0.00% | – |
| Q4 2021 | $567,000 | +0.4% | 56,545 | -0.0% | 0.00% | – |
| Q3 2021 | $565,000 | -0.5% | 56,554 | +0.0% | 0.00% | – |
| Q2 2021 | $568,000 | +15.2% | 56,545 | +13.1% | 0.00% | – |
| Q1 2021 | $493,000 | – | 50,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |